# NCT06985147 (NCT06985147)

> A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06985147
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Disc Medicine, Inc
- Conditions: Polycythemia Vera (PV)
- Interventions: DISC-3405
- Enrollment: 60
- Primary outcome: Number of participants with treatment-related adverse events as assessed by CTCAE
- Primary outcome: Incidence of clinically abnormal vital signs
- Primary outcome: Incidence of clinically abnormal physical exam
- Primary outcome: Incidence of clinically abnormal electrocardiograms
- Primary outcome: Incidence of abnormal laboratory test results

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 3
- YouTube: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=nct06985147